Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Female|Breast Cancer, Male|Breast Cancer Stage I|Breast Cancer Stage II|Breast Cancer Stage III|Residual Disease|HER2-positive Breast Cancer|HER2 Positive Breast Carcinoma
Interventions: BIOLOGICAL: DC1 Vaccine|BIOLOGICAL: WOKVAC Vaccine
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: United States Department of Defense